Cross-sectorial Rehabilitation of Patients with Lung Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCamilla Balle

About this trial

Four thousand seven hundred patients are diagnosed with lung cancer in Denmark every year. Even though cigarette smoking has declined for decades a decline in lung cancer incidence is still at least a decade away. Only 16% of these patients with lung cancer started in a municipal rehabilitation program.

Aim: To investigate if the intervention "early contact conference" can facilitate acceptance of and participation in municipal rehabilitation in patients with lung cancer. Further, to investigate whether the rehabilitation improve the patients' physical ability and quality of life.

Thirteen municipalities from Region Hovedstaden have agreed to participate in this cluster randomized controlled trial. The intervention will focus on creating early contact between the Department of Oncology and the municipalities. The conference call will be planned when the patient is at the hospital for the second systemic treatment and a written status will be sent to the GP after the conference video call so that hospital, municipality, and GP will all have the newest knowledge about the patient's general condition

The intervention will be easy to implement in clinical practice afterwards if it is a success and the cost of the intervention is low.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients diagnosed with NSCLC

1. line systemic treatment

Disqualifiers

cannot speak, understand, and/or read Danish

cognitive/psychologically unfit to give consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • video conference

    Behavioral

    video conference

Treatment groups

130 Participants
are divided into 2 treatment groups
Group A: Intervention group: video conferenceExperimental treatment 1 intervention
Group B: No interventionNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Early contact conference

• Will an "early contact conference" with the primary sector increase the number of patients with NSCLC starting rehabilitation in the municipality?

Time frame
6 months after treatment start

Secondary outcomes

1

Quality of life

• Will Quality of life (Qol) and physical functions increase in patients receiving rehabilitation compared to patients who do not attend rehabilitation? The EORTC QLQ-C30 Measurement of QoL: The EORTC QLQ-C30 30 questions and is designed specifically to assess the QoL of patients with cancer. Measurement of physical function: The 30-second chair stand test (30s-CTS) measures how many times a person can get up from a chair in 30 seconds.

Time frame
EORTC-C30 baseline, 3 weeks, 9 weeks, 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Camilla Balle

Lead sponsor

Copenhagen University Hospital at Herlev

Sponsor institution